Schizophrenia is a life-shortening disease and life expectancy in patients may be 15–20
years shorter than in the general population, with increasing longevity gap over time …

Effective mental health promotion, prevention, and treatment approaches exist but are not
widely delivered at-scale to large groups or populations. Most people who could benefit from …

Background People with severe mental illness have a mortality rate higher than the general
population, living an average of 10–20 years less. Most studies of mortality among people …

Orally administered antipsychotic drugs are the first-line treatment for psychotic disorders,
such as schizophrenia and bipolar disorder. Nevertheless, adverse drug reactions …

Abstract Background and Hypothesis People with severe mental illness (SMI) may
experience excess mortality and inequitable treatment following acute coronary syndrome …

Background Suicide is more prevalent among disadvantaged, discriminated, and
marginalised people with the majority of global suicide deaths occurring in the low-and …

The allostatic load model celebrates its 30-year anniversary in 2023. To date, thousands of
articles (N= 2465) informed by the allostatic load model have expanded theory, research …

Circular RNAs (circRNAs) belong to the genre of long non-coding RNAs that are formed by
special back-splicing events and are currently the molecule of interest for studies globally …

AimsCardiometabolic diseases are responsible for the majority of premature deaths in
people with schizophrenia. This study aimed to quantify the fatal burden of ischaemic heart …

The needs of people with severe mental illness are complex and require a range of services
embedded in well-coordinated systems of care to enable recovery, promote well-being and …